get shot and 21% more likely to have their entire tankcrew killed by the enemy. 4Hearing damage has been a battlefield riskever since the introduction of explosives and artillery,and the U.S. military recognized it in Iraq andAfghanistan and issued earplugs early on. But thesheer number of injuries and their nature, particularlythe high incidence of tinnitus, came as a surprise tomilitary specialists and outside experts. According toVA figures, despite all that has been learned over theyears, U.S. troops are suffering hearing damage atabout the same rate as World War II veterans. 13,21Given today’s unpredictable weaponry (i.e. roadsidebombs), even the best hearing protection is only partlyeffective, and only if it’s properly used.It makes more sense to prevent hearing damagethan to provide a lifetime of disability, but evenhearing protection has its limits and it is important tonote that some hearing impairments are unavoidabledespite use of hearing protection and other measures.Some exposures are so extreme that they will exceedthe protective capability of hearing protective devices.As previously noted, damage can occur at 85 decibels.The best protection cuts that by only 20-25dB. 13 Thatis not enough to protect the ears against an explosionor a firefight, which can range upwards of 180+ dB.Furthermore, much of the fighting consists of ambushes,bombings, and firefights, which come suddenlyand unexpectedly, giving Soldiers little time touse their issued hearing protection. In addition, someInfantrymen resist or refuse to wear their hearing protectionfor fear of dulling their senses and missing criticalcommands or sounds that can make the differencebetween life and death.HBO 2 THERAPY EFFICACY IN TINNITUSMedical treatments for tinnitus are well documentedand there is probably no other disease forwhich such a variety of treatments have been proposed.Yet, still today, many different treatment regimens arebeing propagated. Vasodilators, vitamins, steroids, anticoagulants,heparin, histamine, tranquillizers, diuretics,prostacyclin, hypervolemic hemodilution,carbogen, and stellate ganglion block. 3,25 Whether appliedseparately or together, all have demonstrated limitedeffectiveness at best. Experimentally, rheologicalagents and plasma expanders neither cause an improvementin inner ear blood supply nor result in ahigher oxygen supply in the inner ear. 26 In addition,two forms of tinnitus rehabilitation are currently beingprescribed, tinnitus masking and psychological treatment;both offer symptomatic treatment, with the goalof treatment being only to lessen the awareness of tinnitusand its impact on quality of life.Since the end of the 1960s, hyperbaric oxygen(HBO 2 ) therapy has been used experimentally for certainacute and chronic illnesses of the inner ear. 25 Therole of HBO 2 in the treatment of tinnitus was investigatedin the past: Pilgramm et al. in 1985, firstly, andSchumann et al. in 1990, secondly, reported aboutHBO 2 usefulness in tinnitus treatment, reporting animprovement of 62.2% in 557 patients’ tinnitus afterreceiving 10 applications of HBO 2 therapy. 25,27 Whileskepticism remains high in the Untied <strong>States</strong>, physiciansin Germany and Japan continue to recognize itsclinical applications in diseases of the inner ear andhave demonstrated improved outcomes in the treatmentof acute acoustic trauma, NIHL, and tinnitususing HBO 2 therapy. 7,26 The rationale for this therapyis based on the oxygen transportation mechanism inhuman organisms.The basis for hyperbaric oxygenation is thebreathing of pure oxygen at a pressure which is increasedcompared to atmospheric pressure (1.0ATA). 9,26,28-30 The effectiveness of high pressure oxygentherapy is based on raising the partial pressure ofoxygen in the blood and thus the pressure differenceto tissue. The concentration of oxygen in the atmosphereis 21%. At 1.0 ATA, the oxygen in blood is almostentirely carried by hemoglobin. Becausehemoglobin is approximately 97% saturated under normalconditions, greatly increasing the oxygen-carryingcapacity of blood by increasing hemoglobinsaturation is not possible.During hyperbaric oxygen therapy the patientsits inside a pressurized chamber. Air pressure insidethe chamber is increased up to 2.5 times normal atmosphericpressure at sea level (2.5 ATA). The patientthen breathes pure oxygen from a mask. Inhalation ofhyperbaric oxygen can enhance the amount of oxygencarried in blood by increasing the quantity of oxygendissolved in plasma. When breathing 100% oxygen ata surrounding pressure of 2.5 ATA, the quantity of dissolvedoxygen in 100ml of plasma increases from0.3ml, to 6.8ml, which is approximately 20 timeshigher than normal. 9,26The driving force for oxygen diffusion fromthe capillaries to tissue can be estimated by the differencebetween the partial pressure of oxygen on the arterialside and the venous side of the capillaries. Thedifference in the partial pressure of oxygen from thearterial side to the venous side of the capillary systemis approximately 37 times greater when breathing100% oxygen at 3.0 ATA than air at 1.0 ATA. 29The increased tissue oxygenation achievedduring HBO 2 therapy can support poorly perfused andhypoxic areas. Under this increased pressure, theamount of dissolved oxygen is sufficient, even withouthemoglobin, to supply body tissues with oxygenby diffusion. With an increase of the pressure of oxygenin the inner ear, it is possible to influence the auditorysensory cells (inner and outer hair cells) and theperipheral auditory nerve fibers. 30 These cells have nodirect vascular supply and depend entirely on oxygen36Journal of <strong>Special</strong> <strong>Operations</strong> Medicine Volume 9, Edition 3 / <strong>Summer</strong> 09
supplied by diffusion. During exposure to HBO 2 therapy,the oxygenation in the cochlea increases by 460-600% and is still 60% above normal one hour aftertermination of the therapy. 9,26,30 An increase in oxygenpressure can compensate for oxygen deficiency causedby trauma and gives rise to biological mechanismswhich can facilitate cellular and vascular repair. 9,30 Additionally,HBO 2 therapy has been shown to improvehemorheology by causing a reduction in hematocrit, areduction of platelet aggregation, and an increase in theflexibility of erythrocytes. 31 Hyperoxia has also beenshown to reduce edema by reducing vascular permeabilityand causing a rapid and significant vasoconstriction.29HBO 2 is considered a relatively benign interventionwith few adverse effects. Visual disturbance,usually reduction in visual acuity secondary to conformationalchanges in the lens, and barotrauma, affectingthe middle ear, are the most frequently reported complications.15,16,29 The majority of patients recover spontaneouslyover a period of days to weeks from theirvisual disturbances and most episodes of barotraumado not require the therapy be abandoned. Barotraumaof the middle ear can be treated by placement of pressureequalization tubes or milder cases with decongestantsand/or instruction regarding pressure equalizationtechniques. Less commonly, estimated only to occur inone in 5,000 to 11,000 treatments, HBO 2 may be associatedwith acute central nervous system oxygen toxicity.15,16,29 Exposure to 100% oxygen at 3.0 ATA forthree hours induces grand mal seizures in most people;at less than 3.0 ATA, seizures are rare. 29 Oxygen-inducedseizures are typically benign and produce nolong-term sequelae. Additional complications includebarotraumas affecting the dental cavities and sinuses,pulmonary barotraumas, drug reactions, and injuries ordeath related to chamber fires. Decompression sicknesscan also occur, though rare in patients breathing100% oxygen with short air breaks.CURRENT LITERATUREThe evidence for HBO 2 therapy for acute andchronic tinnitus based on randomized controlled trialsis poor. In July 2004, Bennett et al. underwent an extensivesearch of what they considered to be “suitable”randomized human trials assessing the outcome of tinnituswith HBO 2 therapy. The inclusion criteria consistedof a randomized controlled study, a review withnew data, was not a comparative trial in which all subjects/groupsreceived HBO 2 therapy, subjects were randomlyallocated, and report was not a case study. 15,16The initial search identified six randomized human trialsmeeting the criteria. However, after appraisal of thefull report, three articles were excluded because theydid not contain new data. A follow-on search was conductedby Bennett et al. in 2006; no additional studieswere identified. 16 Using the same inclusion criteria, theauthor of this paper was unable to identify any additionalstudies that met all the criteria, but was able tofind a number of prospective and retrospective studiesevaluating the benefits of HBO 2 therapy for the treatmentof tinnitus.PROSPECTIVE STUDIESTwo of the randomized controlled trials, identifiedby Bennett et al., reported on improvements intinnitus for patients with an early/acute presentation.15,16,26 The Hoffmann et al. 1995a trial contributed20 subjects with idiopathic sudden sensorineural hearingloss (ISSHL) with or without tinnitus; all subjectshad no improvement after 14 days of pharmacologicaltreatment with hydroxyethyl starch, pentoxifylline, andcortisone. The Schwab et al. 1998 trial contributed 33subjects with sudden hearing loss and tinnitus seenwithin two weeks of onset of tinnitus and without anyprior therapy. In each study the HBO 2 group’s therapyconsisted of 100% oxygen at 1.5 ATA for 45 minutesdaily, five days each week for two to four weeks (10 to20 sessions). The control groups underwent no treatment.While the two trials reported a greater mean improvementin tinnitus (using a visual analogue scalebetween 0 and 10) in the HBO 2 arm compared to thecontrol arm, statistical pooling was not possible due tothe authors neglecting to report the standard deviationaround the means. As a consequence, clinical significancecould not be determined.The third article considered suitable, by Hoffmannet al. 1995b, was the only randomized humancontrolled trial reporting on improvements in tinnitusfor patients with a chronic presentation. 15,16 This studycontributed 44 subjects with ISSHL and tinnitus forlonger than six months. HBO 2 therapy consisted of100% oxygen at 1.5 ATA for 45 minutes daily, fivedays each week for three weeks. The control groupbreathed air at 1.5 ATA on the same schedule as theHBO 2 group. While the HBO 2 therapy group diddemonstrate some improvement in tinnitus, the improvementdid not reach statistical significance:p=0.12. 15,16In each of these studies the HBO 2 therapy consistedof breathing 100% oxygen at 1.5 ATA for 45minutes. In studies reporting significant improvements,HBO therapy consisted of breathing 100% oxygenat 2.0 to 2.5 ATA for 90 minutes.In 2007, a comparative trial by Porubsky et al.evaluating the influence of time interval from the onsetof tinnitus until the first HBO 2 therapy was published. 31In addition to time interval, the study compared the influenceof other factors: treatment protocols, gender,noise characteristic, and pretreatment expectations.This author will only comment on treatment protocolsand time interval from tinnitus onset to treatment.In this study, 360 patients suffering from tinnituswere randomized into two HBO 2 treatment pro-Tinnitus, a Military Epidemic:Is Hyperbaric Oxygen Therapy the Answer?37
- Page 1 and 2: Volume 9, Edition 3 / Summer 09 Jou
- Page 3 and 4: An 18D deworms a camel during a “
- Page 5 and 6: Field Evaluation and Management of
- Page 7 and 8: The circumferential anchoring strip
- Page 9 and 10: In doing so, all the skin is closed
- Page 11 and 12: NATO SOF Transformation and theDeve
- Page 13 and 14: current and future operations, thes
- Page 15 and 16: sion of a physician, and limited pr
- Page 17 and 18: REFERENCES1. James L. Jones, “A b
- Page 19 and 20: This article is the first of two me
- Page 21 and 22: Figure 4 : A Special Forces medic c
- Page 23 and 24: exposure. Conversely, the customary
- Page 25 and 26: 7. Ted Westmoreland. (2006). Attrib
- Page 27 and 28: first three days of injury, althoug
- Page 29 and 30: 9. Markgraf CG, Clifton GL, Moody M
- Page 31 and 32: the only sign of OCS may be elevate
- Page 33 and 34: E. The canthotomy allows for additi
- Page 35 and 36: 33. Rosdeutscher, J.D. and Stradelm
- Page 37 and 38: Tinnitus, a Military Epidemic:Is Hy
- Page 39: The development of chronic NIHL pro
- Page 43 and 44: similar to those of other authors,
- Page 45 and 46: promising effect on tinnitus. Howev
- Page 47 and 48: ADDITIONAL REFERENCESHoffmann, G; B
- Page 49 and 50: et al. demonstrated that both right
- Page 51 and 52: TYPICAL CHEST RADIOGRAPH FINDINGS I
- Page 53 and 54: 11. Norsk P, Bonde-Petersen F, Warb
- Page 55 and 56: ABSTRACTS FROM CURRENT LITERATUREMa
- Page 57 and 58: tourniquet times are less than 6 ho
- Page 59 and 60: tal from July 1999 to June 2002. In
- Page 61 and 62: Operation Sadbhavana: Winning Heart
- Page 63 and 64: CENTRAL RETINAL VEIN OCCLUSION IN A
- Page 65 and 66: of the X chromosome. Notable is tha
- Page 67 and 68: AUTHORS*75th Ranger Regiment6420 Da
- Page 69 and 70: Casualties presenting in overt shoc
- Page 71 and 72: PSYCHOLOGICAL RESILIENCE AND POSTDE
- Page 73 and 74: spondents without PTSD (M = 4.6, SD
- Page 75 and 76: patients, whereas the mean score of
- Page 77 and 78: 29. Whealin JM, Ruzek JI, Southwick
- Page 79 and 80: average, time between return from d
- Page 81 and 82: ing functioning in both PTSD (Zatzi
- Page 83 and 84: Editorial Comment on “Psychologic
- Page 85 and 86: Blackburn’s HeadhuntersPhilip Har
- Page 87 and 88: The Battle of Mogadishu:Firsthand A
- Page 89 and 90: Task Force Ranger encountered enemy
- Page 91 and 92:
Peter J. Benson, MDCOL, USACommand
- Page 93 and 94:
Numerous military and civilian gove
- Page 95 and 96:
Anthony M. Griffay, MDCAPT, USNComm
- Page 97 and 98:
This is a great read that speaks di
- Page 99 and 100:
and twenty-eight. Rabies immune glo
- Page 101 and 102:
Rhett Wallace MD FAAFPLTC MC SFS DM
- Page 103 and 104:
LTC Craig A. Myatt, Ph.D., HQ USSOC
- Page 105 and 106:
LTC Bill Bosworth, DVM, USSOCOM Vet
- Page 107 and 108:
Europe, Mideast, Africa and SWAU.S.
- Page 109 and 110:
SOF and SOF Medicine Book ListWe ha
- Page 111 and 112:
TITLE AUTHOR ISBNCohesion, the Key
- Page 113 and 114:
TITLE AUTHOR ISBNI Acted from Princ
- Page 115 and 116:
TITLE AUTHOR ISBNRats, Lice, & Hist
- Page 117 and 118:
TITLE AUTHOR ISBNThe Healer’s Roa
- Page 119 and 120:
TITLE AUTHOR ISBNGuerilla warfare N
- Page 121 and 122:
TITLEAUTHORBlack Eagles(Fiction)Bla
- Page 123 and 124:
TITLE(Good section on Merrill’s M
- Page 125 and 126:
GENERAL REFERENCESALERTS & THREATSB
- Page 127 and 128:
Aviation Medicine Resources: http:/
- Page 129 and 130:
LABORATORYClinical Lab Science Reso
- Page 131 and 132:
A 11 year old boy whose tibia conti
- Page 133 and 134:
Meet Your JSOM StaffEXECUTIVE EDITO
- Page 135 and 136:
Special Forces Aidman's PledgeAs a